Long Term Safety and Efficacy Study of Tolebrutinib (SAR442168) in Participants With Relapsing Multiple Sclerosis

Clinical trial NCT03996291 · COMPLETED

Trial details

NCT number: NCT03996291
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsing Multiple Sclerosis

Start date: 2019-09-23
Primary completion: 2024-11-26
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.